Company: ZVRA
Filing Date: 2025-03-31
Form Type: PREC14A
Source: 0001193125-25-068746
Chunk: 43

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: PREC14A
Chunk 43
---
 adjustments to their compensation as well as awards to be granted. For all executive officers, as part of its deliberations, the Compensation Committee may review and consider, as appropriate, materials such as financial reports and projections, operational data, tax and accounting information, tally sheets that set forth the total compensation that may become payable to executives in various hypothetical scenarios, executive stock ownership information, company stock performance data, analyses of historical

<div align='center'>39</div>

executive compensation levels and current company-wide compensation levels and recommendations of the Compensation Committee’s compensation consultant, including analyses of executive compensation paid at other companies identified by the consultant. Nominating and Corporate Governance Committee The Nominating and Corporate Governance Committee is composed of three directors, Thomas D. Anderson, John B. Bode and Alvin Shih, M.D. Mr. Bode is the chair of the Nominating and Corporate Governance Committee. All members of the Nominating and Corporate Governance Committee are independent under the Nasdaq listing standards. The principal duties and responsibilities of the Nominating and Corporate Governance Committee include:

| • |     | identifying, reviewing and evaluating candidates to serve as our directors (consistent with criteria approved by the Board), and recommending prospective director candidates to the Board to serve as directors; |

| • |     | serving as a focal point for communication between director candidates, non-committee directors and the Company’s management; |

| • |     | reviewing and evaluating the performance of incumbent directors and the performance of the full Board and Board committees; |

| • |     | making recommendations to the Board regarding affairs relating to the directors of the Company, including regarding the membership of the committees of the Board; |

| • |     | making recommendations to the Board regarding corporate governance issues; |

| • |     | overseeing and reviewing the processes and procedures used to provide information to the Board and its committees; |

| • |     | reviewing with the Chief Executive Officer the plans for succession to the offices of Chief Executive Officer and other key executive officers and making recommendations to the Board with respect to succession planning; |

| • |     | reviewing Company policy statements to determine their adherence to our Code of Conduct and considering any request by our directors or executive officers for a waiver from the Code of Conduct; and |

| • |     | overseeing and reviewing the Company’s corporate governance functions on behalf of the Board, including reviewing and assessing the adequacy of our Amended and Restated Certificate of Incorporation, Bylaws and Board committee charters. |

The N